naphthalenediimide has been researched along with Pancreatic Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, AA; Marchetti, C; Neidle, S; Ohnmacht, SA | 1 |
| Collie, GW; Dale, AG; Gunaratnam, M; Micco, M; Neidle, S; Ohnmacht, SA; Pazitna, I; Reszka, AP | 1 |
| Besser, RJ; Di Vita, G; Diocou, S; Gunaratnam, M; Haider, SM; Hartley, JA; Islam, B; Lowe, HL; Marchetti, C; Mellinas-Gomez, M; Neidle, S; Ohnmacht, SA; Pedley, RB; Robson, M; Šponer, J | 1 |
| de la Fuente, M; Gunaratnam, M; Hampel, SM; Neidle, S; Reszka, AP; Schätzlein, A; Todd, AK | 1 |
4 other study(ies) available for naphthalenediimide and Pancreatic Neoplasms
| Article | Year |
|---|---|
A G-quadruplex-binding compound shows potent activity in human gemcitabine-resistant pancreatic cancer cells.
Topics: Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Survival; Deoxycytidine; Down-Regulation; Drug Resistance, Neoplasm; G-Quadruplexes; Gemcitabine; Gene Expression Profiling; Humans; Imides; Ligands; Naphthalenes; Pancreatic Neoplasms; Repressor Proteins; Up-Regulation | 2020 |
Structure-based design and evaluation of naphthalene diimide G-quadruplex ligands as telomere targeting agents in pancreatic cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Design; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; G-Quadruplexes; Humans; Imides; Ligands; Models, Molecular; Naphthalenes; Pancreatic Neoplasms; Telomere | 2013 |
A G-quadruplex-binding compound showing anti-tumour activity in an in vivo model for pancreatic cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Administration Schedule; Female; G-Quadruplexes; Gene Expression; Humans; Imides; Injections, Intravenous; Mice; Mice, Nude; Molecular Dynamics Simulation; Naphthalenes; Pancreatic Neoplasms; Promoter Regions, Genetic; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins p21(ras); Transcription, Genetic; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
Targeting pancreatic cancer with a G-quadruplex ligand.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Female; G-Quadruplexes; HSP90 Heat-Shock Proteins; Humans; Imides; Ligands; Mice; Mice, Nude; Naphthalenes; Pancreatic Neoplasms; Promoter Regions, Genetic; Telomerase; Xenograft Model Antitumor Assays | 2011 |